10.1186/s13098-022-00924-8 Summary Keywords GLP-1 receptor agonists, DPP-4 inhibitors, FAERS, adverse events, biliary disorders, pharmacovigilance Citation He L, Li J, Cheng X, Luo L and Huang Y (2025) Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
Scott is an active member of the Washington community
The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis
Uyku sresini 7-8 saate ekmek, melatonin sentezi yoluyla mitokondriyal antioksidan savunmay kuvvetlendirir
Latest Articles Medical Malpractice Trends: What Providers are Getting Sued for in 2026 Why Nurse Practitioners Are Turning Toward Integrative Psychiatry for Treatment Resistance When Seasonal Depression Doesnt Lift With Spring Why Nurses Sleep Worse in Winter and Evidence-Based Ways to Fix It The New Epidemic: Cognitive Fatigue in Healthcare Workers Featured Course Talking About Suicide: New Language from Social Media and Current Guidelines N598 Free Course Drug Diversion Training Most Popular Unlimited Perfect for RNs, LPNs, and LVNs A full year of unlimited CE Save over $150* Instant access to all courses Instant access to certificates CE Broker reporting included Take CE on any device No tests required in most states 1 $59.00 / yearAdd to Cart Join Our Mailing List Get news, perspectives, special offers, new course alerts, and renewal date reminders straight to your inbox
